Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria-Reference-Cited by-同舟云学术

Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria

Published:2024-08-27 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Jang Se Young,Park Soo Young,Kweon Young Oh,Lee Yu Rim,Ryeom Hun Kyu,Cha Jung Guen,Kim Sungmin,Lee Won Kee,Jo Ae Jeong,Tak Won Young

Funder

the National Research Foundation (NRF) grants funded by the Korean government

National Research Foundation (NRF) grants funded by the Korean government

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-70494-4.pdf

Reference26 articles.

1. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol. 69(1) 182–236 (2018).

2. Cucchetti, A. et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J. Hepatol. 59(2), 300–307 (2013).

3. Choi, D. et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large single-institution series. Eur. Radiol. 17(3), 684–692 (2007).

4. Kim, Y. S. et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J. Hepatol. 58(1), 89–97 (2013).

5. Lencioni, R. et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234(3), 961–967 (2005).